Dr. Reddys Laboratories Ltd.

Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended, Dr. Reddy’s Laboratories has informed enclosed copies of newspaper advertisement regarding the unaudited financial results of the company for the quarter and half-year ended September 30, 2022, as published in Financial Express and Andhra Prabha on October 30, 2022.

The above information is a part of company’s filings submitted to BSE.